Getting latest data loading
X

Request a Call to Trade

In addition to the daily Research emails, I would also like to receive the Accendo Markets Weekly Newsletter and occasional Market Report emails highlighting various trading opportunities.
When you enter your telephone number, we may call or message you occasionally with trading opportunities. You can opt out at any time

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Upgrades/Downgrades - 13 December 2013

This page refreshes automatically every 30 mins. Press F5 to update manually

For a more detailed explanation of Upgrades/Downgrades see Link

Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained

Stock Broker Update
AstraZeneca SocGen ups TP to 2740p from 2700p, underweight
Astrazeneca Jefferies ups TP to 2800p from 2600p, underperform
Barclays Numis ups to Hold from reduce; ups TP to 274p from 222p
Bunzl HSBC ups TP to 1425p from 1360p, neutral
Centrica SocGen downgrades to Hold from Buy, cuts TP to 315p from 410p
Domino Printing Sciences UBS downgrades to neutral from Buy; ups TP to 720p from 700p
Experian HSBC cuts TP to 1300p from 1500p, overweight
John Wood Group HSBC cuts TP to 740p from 860p, neutral
Source: Reuters News, AlphaTerminal, Dow Jones Newswires

Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires

Back to Top

T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.